Yumizen C1200, Yumizen C1200 Glucose HK, Sodium Electrode, Potassium Electrode, Chloride Electrode
Analyzer, Chemistry (Photometric, Discrete), For Clinical Use. 510(k) K183375, from Horiba, Ltd. (Kyoto, JP). Product code JJE, class 1.
As of Nov 17, 2026, K183375 is an FDA 510(k) held by Horiba, Ltd., substantially equivalent on Feb 12, 2019 after 68 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Feb 12, 2019
- Review time: 68 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Yumizen C1200 Glucose HK reagent is intended for the quantitative in vitro diagnostic determination of glucose in human serum, plasma, and urine using a glucose hexokinase method by colorimetry. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell…
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- ISE Reagent, Glucose, CRP Latex, DxC 700 AU Clinical Chemistry AnalyzerK161837 · Beckman Coulter, Inc. · Dec 16, 2016
- Abx Pentra Glucose Hk Cp, Abx Pentra Uric Acid Cp, Abx Pentra Urine Control L/HK081276 · Horiba Abx · Sep 12, 2008
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 6, 2018
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.2160
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files